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Abstract. Toxoplasmosis is an important parasitic disease in immunosuppressed 
patients. This prospective study was conducted to determine the seroprevalence, 
associated risk factors and the incidence of clinically confirmed toxoplasmosis 
among renal patients at the University of Malaya Medical Center, Kuala Lum-
pur, Malaysia. We interviewed 247 renal patients, each of whom answered an 
epidemiological questionnaire, and collected blood samples for measurement 
of anti-Toxoplasma IgG and IgM antibodies by ELISA. Overall seroprevalence of 
latent toxoplasmosis was observed in 126 (51%) renal patients. Race (Malays), 
marital status (married) and primary level of education, were all factors associ-
ated with a greater chance of Toxoplasma infection. A case of clinically confirned 
toxoplasmosis was diagnosed in a renal transplant recipient as a result of immu-
nosuppression. Based on the findings obtained, this preliminary study shows a 
high prevalence of latent toxoplasmosis in renal patients. Risk factors may have 
significantly contributed to Toxoplasma acquisition in these patients. We recom-
mend further studies be carried out to monitor for trends in toxoplasmosis among 
immunosuppressed patients.
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INTRODUCTION
Toxoplasmosis is a zoonotic disease 
caused by Toxoplasma gondii, an ubiq-
uitous intracellular protozoan parasite. 
This cosmopolitan parasite is transmitted 
to humans by ingestion of oocysts shed 
by cats in the environment, ingestion 
of undercooked or raw infected meat, 
transplacentally, and through organ trans-
plantation. Toxoplasmosis is an important 
parasitic disease in humans which is 
generally asymptomatic in immunocom-
petent persons. Toxoplasmosis is the most 
frequent protozoal opportunistic infection 
in immunocompromised individuals. Its 
association with immunosuppression has 
been known for several decades. Dissemi-
nated disease has been observed in solid 
organ transplant patients (Ferreira and 
Borges, 2002). Although new infections 
may be contracted in immunosuppressed 
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patients, the most common manifestation 
is reactivation of a previously latent infec-
tion (Wreghitt and Joynson, 2001). T. gondii 
antibody prevalence rates vary greatly by 
geographic distribution and population 
among healthy persons (Pordeus et al, 
2008), pregnant women (Nissapatorn et al, 
2003), immunocompromised patients, in-
cluding those with HIV/AIDS (Lindström 
et al, 2006), cancer (Rai et al, 2003), end 
stage renal disease (ESRD) undergoing 
hemodialysis (Yazar et al, 2003) and those 
having had organ transplantation (Suk-
thana et al, 2001). This impact of T. gondii 
on public health has raised an interest in 
better understanding of its pathology and 
consequences.  No studies of the clinico-
epidemiological aspects of toxoplasmosis 
in renal patients have been carried out in 
Malaysia.
This study, therefore, aims to deter-
mine the seroprevalence of toxoplasmosis 
in renal patients, the association between 
possible and confounding risk factors 
and Toxoplasma seropositivity, and to 
determine the incidence of clinically con-
firmed toxoplasmosis in renal patients. 
This study highlights the significance of 
this parasitic infection and the need  to 
improve awareness of this parasite and 




A prospective cross-sectional study 
was conducted at the Department of Med-
icine (Nephrology Unit), which includes 
an outpatient clinic, inpatient ward, he-
modialysis, and transplantation units of 
the University of Malaya Medical Center 
(UMMC), Kuala Lumpur, from May 2007 
to March 2008. This study was approved 
(Ref. No. 552.18) by the ethics commit-
tee from this center. The study included 
247 eligible subjects who gave informed 
consent prior to enrollment in the study. 
Inclusion criteria were: 1) age >15 years, 
2) negative anti-HIV antibody serostatus 
by ELISA technique, and 3) two hundred 
forty-seven renal patients include 79 
patients with renal failure (1 with acute 
renal failure and 78 with chronic renal 
failure), 143 patients with end stage renal 
disease undergoing hemodialysis, 25 renal 
transplant patients, including 3 new and 
22 known cases. Of the 247 renal patients, 
184 had secondary causes for their renal 
failure, including hypertension, diabetes 
mellitus and heart diseases, 46 had both 
primary and secondary causes for renal 
disease, 16 had a primary cause for renal 
disease, such as systemic lupus erythre-
matosus (SLE), small kidneys or glomeru-
lonephritis and 1 patient had an unknown 
cause of renal disease. The duration of the 
underlying cause in these patients ranged 
from < 1 year to 30 years, with a median 
of 10 years. 
A questionaire was designed to detect 
sociodemographic and biologically plau-
sible risk factors for toxoplasmosis, as well 
as clinical history, presenting signs and 
symptoms, investigations and treatment 
outcomes relating to toxoplasmosis. An 
operational definition was used for the risk 
factors. Contact with cats was defined as 
being an owner of at least one cat or coming 
into close contact with cats through play-
ing with, feeding or sleeping with cats in 
the house. Consumption of undercooked 
or raw meat was defined as one who had 
the habit of eating undercooked meat, 
such as sausage, sashimi, satay, barbecue 
or any kind of meat where the method 
of preparation could not be guaranteed. 
Blood transfusion was defined as one who 
had received blood (or blood products) at 
least 3 months prior to the study period. 
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Serum samples
Approximately 5 ml of venous blood 
was drawn from a subject then the sera 
were kept at -20ºC until used.
Detection of IgG and IgM antibodies to 
Toxoplasma gondii 
Toxoplasmosis was screened by us-
ing a standard ELISA commercial kit 
(IgG-Trinity Biotech, New York, NY and 
IgM-Trinity Biotech, New York, NY) in ac-
cordance with the manufacturer’s instruc-
tions and performed at the Department of 
Parasitology, University of Malaya Medi-
cal Center, Kuala Lumpur. A result of >51 
IU/ml of anti-Toxoplasma IgG antibody was 
regarded as positive, indicating latent or 
pre-existing Toxoplasma infection; a result 
>51 IU/ml of anti-Toxoplasma IgM anti-
body was regarded as positive, indicating 
a recently acquired Toxoplasma infection. 
Anti-Toxoplasma IgG  and IgM antibodies 
were used to screen patients with renal 
disease. In new renal transplant patients, 
donors were  screened for anti-Toxoplasma 
(IgG/IgM) antibodies prior to donation 
and recipients were screened 1-3 months 
after transplant. 
Statistical analysis 
Data obtained from both the question-
naire and laboratory tests were entered, 
edited and analyzed using the statistical 
software SPSS version 10 (SPSS, Chicago, 
IL). The data with quantitative variables 
were expressed as means (± SD) and rang-
es, whereas, qualitative variables were 
estimated and presented as frequencies 
and percentages. The c2 test was chosen to 
test differences by gender, seroprevalence 
of toxoplasmosis and determine the asso-
ciation between possible risk factors and 
disease transmission. Multivariate analy-
sis adjusted by multiple logistic regression 
was used to determine significant differ-
enes in demographics and confounding 
risk factors used to determine seropositiv-
ity rates among study subjects. A p <0.05 
was regarded as statistically significant. 
RESULTS
Seroprevalence of toxoplasmosis in renal 
patients
The seroprevalence of toxoplasmosis 
in renal patients was found to be 56.7% 
(140/247) in whom 46.6% (115, 95% CI 40-
52) were positive for anti-Toxoplasma IgG 
antibody (latent infection), 5.7% (14, 95% 
CI 3.4-9.3) were positive for anti-Toxoplas-
ma IgM antibody, and the remaining 4.5% 
(11, 95% CI 2.5-7.8) were positive for both 
anti-Toxoplasma IgG and IgM antibodies, 
as shown in Table 1.
Seroprevalence of toxoplasmosis in rela-
tion to demographic characteristics and 
risk factors
During this study period, a total 
number of 247 subjects were recruited 
ELISA test 
 IgG positive IgM positive Both IgG and IgM positive
Positive 115 (46.6, 95%CI 40-52) 14 (5.7, 95%CI 3.4-9.3) 11 (4.5, 95%CI 2.5-7.8)
Negative 132 (53.4%) 233 (94.3%) 236 (95.5%)
Total 247 247 247
Table 1
Seroprevalence of toxoplasmosis in renal patients as assessed by the ELISA test.
Total number of Toxoplasma seropositive renal patients = 140 (56.7%)
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Characteristic   p-value
  Total  Toxoplasma positivitya 
  (n, %) (n, %) 
  N=247  N=126 
Age
 Range 21-89 years
 Mean 56.7±13.96 years
Age group     0.042
 21-40   30  (12.2)     9  (30) 
 41-60 117  (47.4)   61 (52.1) 
 ≥61 100  (40.5)   56  (56) 
Sex     0.881
 Male 140  (56.7)   72  (51.4) 
 Female 107  (43.3)   54  (50.5) 
Race     0.004
 Malay   82  (33.2)   54  (65.9) 
 Chinese 123  (49.8)   52  (42.3) 
 Indian   42  (17.0)   20  (47.6) 
Marital status     0.000
 Single    25  (10.1)     4  (16.0) 
 Married 222  (89.9) 122  (55.0) 
Address     0.074
 Kuala Lumpur   46  (18.6)   18  (39.1) 
 Outsider 210  (81.4) 108  (51.4) 
Occupation     0.129
 Laborer     8  (3.2)     5  (62.5) 
 Non-laborer   45  (18.2)   17  (37.8) 
 Unemployed 194  (78.5) 104  (53.6) 
Education     0.04
 Primary 107  (43.3)   64  (59.8) 
 Secondary 112  (45.3)   51  (45.5) 
 Tertiary   28  (11.3)   11  (39.3) 
Past history of drug use     0.333
 No drug use 234  (94.7) 117  (50.0) 
 Drug related to ATT     5  (2.0)     4  (80.0) 
 Drug unrelated to ATT     8  (3.2)     5  (62.5) 
Type of renal diseases     0.04
 Renal failure (acute and chronic)   79  (32.0)   41  (51.9) 
 End-stage renal disease with hemodialysis 143  (57.9)   78  (54.6) 
 End-stage renal disease with renal transplant   25  (10.1)    7  (28) 
Table 2
The seroprevalence of toxoplasmosis in renal patients by the demographic 
characteristics.
aOverall seroprevalence of anti-Toxoplasma IgG antibody (126, 51%) in the study subjects.
Renal patients
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in our study. The age range in renal 
patients was 21-89 with a mean of 56.7 
± 13.96 years. Majority of the main age 
group was between 41 and 60 years (117, 
47.4%). Majority of these patients were 
males (140, 56.7%), Chinese (123, 49.8%), 
married (222, 89.9%), and stayed outside 
Kuala Lumpur (210, 81.4%). Most were 
unemployed (194, 78.5%), had received 
secondary level of education (112, 45.3%). 
It was found that a large number of renal 
patients who participated in this study 
had no history of antibiotic use (234, 
94.7%) and were diagnosed having end-
stage renal disease with hemodialysis 
(143, 57.9%). As a single risk factor, this 
study found that age group, race, mari-
tal status, level of education, and type 
of renal diseases were significantly as-
sociated with Toxoplasma seroprevalence 
(p<0.05), as shown in Tables 2 and 3. After 
multi-logistic analysis was applied, it 
was interesting to find that race (Malay), 
marital status (married) and primary level 
of education were identified as significant 
risks for Toxoplasma infection, as shown 
in Table 4.
A case report of active and disseminated 
toxoplasmosis in a post-renal transplant 
recipient
A female patient, born in 1972, had 
bilateral small kidneys and underwent 
a first renal transplant from a cadaveric 
donor, in June 1997; the transplant was a 
success although part of the operative re-
covery was complicated by the re-implant- 
ation of her ureter from the peritoneum 
to the bladder. Her graft function was not 
perfect and she was left with a moderate 
degree of renal failure and anemia. Im-
munosuppressive therapy consisted of 
Prednisolone, FK 506 (tacrolimus), and 
Myfortic. From 1997-2006, she was regu-
larly followed up (every 2-3 months) and 
had health problems from time to time, 
including recurrent urinary tract infec-
Characteristic   p-value
  Total (n, %) Toxoplasma positivitya (n, %)
  N=247 N=126
 
Contact with cats     0.364
 Yes   27  (10.9)   16  (59.3) 
 No 220  (89.1) 110  (50.0) 
Consumption of uncooked meat     0.012
 Yes   23  (9.3)     6  (26.1) 
 No 224  (90.7) 120  (53.6) 
Receiving blood transfusion     0.991
 Yes    53  (21.5)   27  (50.9) 
 No 194  (78.5)   99  (51.0) 
Drinking water      0.665
 Boiled/filtered    16  (6.5)     9  (56.3) 
 Pipe/tap/rain 231  (93.5) 117  (50.7)
Table 3
The seroprevalence of toxoplasmosis in renal patients by plausible risk factors.
Renal patients
aOverall seroprevalence of anti-Toxoplasma IgG antibody (126, 51%) in the study subjects.
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tion, nephritis, a vaginal polyp, dengue 
fever, E. coli bacteremia, hypertension 
and varicella infection. She had multiple 
blood transfusions and drug allergies. In 
January 2007, she had 2 weeks of blurred 
vision of the right eye and 1 week of 
diarrhea for which she was admitted to 
this hospital. On funduscopic examina-
tion, her right eye had a swollen disc, 
was hyperemic, had an infiltrate with 
Roth’s spots, and deep retinal necrosis. 
Physical examination showed no further 
abnormalities. At this point, foscarnet and 
ganciclovir were given intravenously due 
to suspicion of cytomegalovirus (CMV) 
retinitis. Laboratory examination revealed 
an elevated creatinine of 265 (nomal value, 
62-115 µmol/l), a urea of 20 (normal value, 
2.5-6.5 mmol/l), a leukocyte differential 
of 85% of neutrophils, an erythrocyte 
sedimentation rate of 42 mm/hr (normal 
range:, 3-9 mm/hr); PCR assays for CMV 
and Herpes Simplex were negative. Toxo-
plasmosis was considered a diagnostic 
possibility. Serologic testing for Toxoplas-
ma antibodies was positive for both IgG 
and IgM antibodies. A PCR assay for T. 
gondii was positive on a CSF sample. It is 
not known what the Toxoplasma serostatus 
of the renal transplant donor or the recipi-
Variable Adjusted odds ratio (OR) 95% CI p-value
Age ≥ 41 years 0.91 0.31              2.66 0.87
Malays 2.65 1.48              4.74 0.001
Married 5.84 1.62            21.09 0.007
Primary level of education 2.13 1.22              3.72 0.008
End-stage renal disease 0.92 0.52              1.64 0.78
Table 4
Multivariate logistic regression analysis for various risk factors associated with 
Toxoplasma seropositivea renal patients.
aOverall seroprevalence of anti-Toxoplasma IgG antibody (126, 51%) in the study subjects. Adjusted 
variables included age group, race, marital status, level of education, and types of renal disease in 
this statistical analysis.
ent were at the time of transplantation. A 
positive anti-Toxoplasma (IgG) antibody 
was found on a subsequent serum sample 
1 month after treatment. After admission, 
her clinical condition deteriorated, with 
one generalized tonic clonic seizure for 
which phenytoin was given. A computed 
tomography scan showed no abnormali-
ties. The cerebrospinal fluid (CSF) showed 
both elevated protein and leukocyte 
levels (1.27 g/l and 60/ml, respectively). A 
presumptive diagnosis of toxoplasmosis 
was made based on clinical features and 
laboratory evidence. The patient was suc-
cessfully treated with a combination of 
clindamycin (600 mg, qid) and Fansidar 
(1 tab once a week) for 6 weeks. She made 
a full ophthalmoscopic recovery, includ-
ing visual improvement, and had only an 
old scarred lesion but no acute retinitis. 
Clindamycin, a continuing life-long sec-
ondary chemoprophylaxis, was started 
because of chronic immunosuppression 
by steroid in this post-renal transplant 
patient. 
DISCUSSION
Overall, the seroprevalence of latent 
Toxoplasma infection was found in more 
Toxoplasmosis in Renal paTienTs
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than half of renal patients, which is not 
surprising. Malaysia is endemics for 
toxoplasmosis and has been documented 
in other high risk patients (Ravichandran 
et al, 1998; Nissapatorn et al, 2007). Toxo-
plasmosis has a high prevalence in other 
groups of immunosuppressed patients, 
such as cancer and AIDS patients (Ekweo-
zor et al, 1994; Nissapatorn et al, 2004). The 
risk for infection in individual patients 
depends on two factors: the prevalence 
of toxoplasmosis in the community and 
the degree and nature of immunosup-
pression (Wreghitt and Joynson, 2001). 
The seroprevalence of Toxoplasma infection 
among ESRD patients on hemodialysis 
was 31.6%. This prevalence is lower than 
other studies from different countries: 
38.3% in Egypt (Abbas et al, 1996) and 
56.1-76.5% in Turkey (Yazar et al, 2003; 
Ocak et al, 2005). Survelliance should be 
periodically performed in highly endemic 
areas to monitor for latent stages of toxo-
plasmosis and seroconversion among 
immunosuppressed patients. The preva-
lence of latent toxoplasmosis was 5.6% in 
post-renal transplant recipients. There are 
a few studies reporting the seroprevalence 
of toxoplasmosis (11% to 67.1%) in renal 
transplant recipients (Figueiredo et al, 
1983; Derouin et al, 1987; Sukthana et al, 
2001; Iqba et al, 2003; Gourishankar et al, 
2008). Despite the low prevalence of latent 
toxoplasmosis among renal transplant 
recipients, we support routine screening 
for toxoplasmosis in donors and recipients 
prior to transplantation to obtain baseline 
serodiagnosis and evaluate the potential 
risk for toxoplasmosis after transplanta-
tion (Iqba et al, 2003). 
The seroprevalence of recently ac-
quired toxoplasmosis was low in renal 
patients. No infections were found in 3 
new renal transplant recipients (before 
or after the transplant) or their donors 
(prior to the transplant). The risk of 
donor-acquired toxoplasmosis in renal 
transplant recipients is much lower than 
other organ tranplant recipients, such 
as heart or liver (Wreghitt and Joynson, 
2001). The presence of IgM antibodies 
in a donor is not necessarily a reason to 
reject the kidneys, but it should lead to 
close clinical and laboratory monitoring 
of the recipients to ensure the earliest start 
of specific treatment if toxoplasmosis is 
suspected (Renoult et al, 1997). Six week 
prophylactic treatment (Sukthana et al, 
2001) should be considered as the other 
option to be given to renal transplant 
recipients receiving kidneys from a Toxo-
plasma seropositive donor. 
An important question is whether 
risk assessment should play a more im-
portant role in screening. A higher rate 
of toxoplasmosis was found among older 
patients, which is not surprising due to 
the fact these patients usually have a well 
established socioeconomic status leading 
to greater risk of exposure to Toxoplasma 
than younger patients. Toxoplasma infec-
tion was more common among Malays 
than other ethnic groups, especially in 
those with a lower education level. Close 
contact with cats as domestic pets is com-
mon among these people. Based on the re-
sults obtained, there are demographic risk 
factors for acquiring Toxoplasma infection. 
Health education regarding toxoplasmo-
sis and its consequences need to be given 
to prevent primary infection among the 
general population irrespective of their 
race or socioeconomic status.
More than half the seropositive pa-
tients in our study had close contact with 
cats. These findings are similar to other 
studies conducted among renal transplant 
recipients (Sukthana et al, 2001) and in HIV-
infected patients (Wallace et al, 1993; Nis-
sapatorn et al, 2001, 2002). This suggests 
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cats play an important role in transmitting 
Toxoplasma infection. Prevention involves 
common sense measures, such as adequate 
hand washing, proper disposal of animal 
waste, and ensuring that infected cats are 
diagnosed and treated (Rabinowitz et al, 
2007) to reduce transmission. Special pre-
cautions should be taken in immunosup-
pressed patients. Only 26% of seropositive 
patients had eaten uncooked meat. Meat 
contaminated with T. gondii has the poten-
tial to spread infection to a large number 
of people (Magaldi et al, 1969; Teutsch 
et al, 1979; Choi et al, 1997; Carme et al, 
2002). Our findings indicate these people 
generally are well cooked food, include 
meat. Immunosuppressed patients should 
follow good personal hygienic in food 
handling and preparation. Our results 
show half of seropositive patients received 
blood transfusions. Blood transfusion is 
generally not a major cause of Toxoplasma 
transmission, but in endemic areas Toxo-
plasma screening should be considered. 
When considering blood transfusion for 
immunocompromised or immunosup-
pressed patients, it would be wise to 
exclude those with chronic toxoplasmosis 
(Al-Amari, 1994). Drinking contaminated 
water has been implicated as a source of 
Toxoplasma infection in humans worldwide 
(Martínez Sáchez et al, 1991; Ertug et al, 
2005;  Lin et al, 2008), and was found in half 
our seropositive patients. However, there 
were no statistically significant association 
between these risk factors and Toxoplasma 
seropostivity in our study. Future studies 
with a larger sample size are recommened 
to verify these associations in immunosup-
pressed patients.
To our knowledge, this is the first 
study of toxoplasmosis among renal trans-
plant recipients in Malaysia. Toxoplasmo-
sis in patients with renal transplantation 
has received little attention and remains 
a rare but serious pathogen in renal 
transplant recipients (Renoult et al, 1997; 
Barsoum, 2004). The incidence was low in 
these kidney recipients, coinciding with 
a low incidence worldwide. Most cases 
of toxoplasmosis in immunosuppressed 
patients result from secondary reacti-
vation of latent infection. This patient 
developed reactivation of  toxoplasmosis 
10 years after renal transplant, similar to 
other studies describing infection up to 
7 years after transplantation (Da Cunha 
et al, 1994; Aubert et al, 1996; Renoult 
et al, 1997; Giordano et al, 2002). Only 35 
cases of visceral or cerebral toxoplasmosis 
complicating renal transplantation have 
been described (Wulf et al, 2005). The 
diagnosis of either focal or disseminated 
toxoplasmosis is based on the clinical 
presentations, with routine and specific 
investigations. It is imperative that clini-
cians have a high index of suspicion for 
toxoplasmosis in immunosuppressed 
patients who present with neurological 
or ocular symptoms. Serological diagnosis 
is useful for early screening of Toxoplasma 
serostatus, as seen in this patient before 
and after treatment. In a patient who 
was Toxoplasma seronegative or has an 
unknown serostatus (Wulf et al, 2005), 
it does not exclude the diagnosis. Other 
antibodies, such as IgA and IgE, have 
emerged as interesting markers for toxo-
plasmosis in  immunosuppressed patients 
and may provide valuable assistance in 
the diagnosis, since tests for specific IgM 
are disappointing (Pinon et al, 1995). This 
patient’s diagnosis was confirmed by 
polymerase chain reaction (PCR) to detect 
Toxoplasma DNA; this method is useful for 
detecting disseminated disease (Johnson 
et al, 1993; Khalifa et al, 1994; Aubert et al, 
1996; Lewis et al, 2002; Wulf et al, 2005). 
This suggests routine serologic testing 
after organ transplantation should be 
Toxoplasmosis in Renal paTienTs
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backed up by PCR when clinical manifes-
tations are consistent with toxoplasmosis 
(Aubert et al, 1996). The diagnosis of 
Toxoplasma infection is complex because 
the immune response in these patients is 
low; clinical awareness of the possiblity of 
infection is therefore important (Wreghitt 
and  Joynson, 2001). Toxoplasmosis can 
result in significant morbidity and mortal-
ity in immunosuppressed patients. Early 
diagnosis and treatment, are important in 
this life-threatening condition. Life-long 
secondary chemoprophylaxis should be 
given to prevent recurrence of toxoplas-
mosis in immunosuppressed patients.
In conclusion, this preliminary study 
shows a high prevalence of latent toxo-
plasmosis in renal patients. A case of clini-
cally confirned toxoplasmosis occurred as 
a result of immunosuppression. We rec-
ommend further studies to determine the 
changing epidemiology of toxoplasmosis 
in immunosuppressed patients.
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